Latest News
2024 Breakthroughs and 2025 Innovations in Neuroscience Phase I Clinical Trials
Utility of TMS and EEG in Phase 1 Drug Trials for Alzheimer’s Disease
MHRA Timelines Back on Track
Enhancing Drug Abuse Potential Assessments: The Role of Cognitive Test Batteries and Neuroimaging Techniques in Human Clinical Trials
A Promising New Drug for Treating Cognitive Decline in Schizophrenia
The Science Behind Supports Rare Disease Day
Recognised as the Best in Early Phase Neuroscience Clinical Trials.
Revolutionising Drug Development: The Power of TMS-EEG in First in Human Clinical Trials
Webinar: Embedding neuroscience for target engagement in FiH clinical trials
Two ISO Standards awarded to The Science Behind